-
Astellas Releases Results of Discontinued Phase 1b Study of ASP0367
Astellas has shared results of the Phase 1b study of ASP0367 (MA-0211), an oral investigational drug. The study aimed to evaluate safety, tolerability, and preliminary efficacy in individuals living with Duchenne aged 8 to 16 years old. The study was stopped early, in November 2022, because not enough patients were available to take part in the study. While…
-
PPMD Hosts 2024 Duchenne Healthcare Professionals Summit
Each January, PPMD brings together experts in the field for our Duchenne Healthcare Professionals Summit to ensure that caring for individuals with the latest information and technology remains a constant priority. Healthcare professionals from PPMD’s Certified Duchenne Care Centers and other neuromuscular programs providing dystrophinopathy care, as well as researchers, academics, and industry partners, gather…
-
Turning Challenges into Opportunities: A Conversation With Justin Skeesuck From “I’ll Push You”
Justin Skeesuck, a 48-year-old Idahoan featured in the documentary “I’ll Push You,” started losing the use of his hands in 2010. So, in 2012, he moved to Italy. For a lot of people that might not make a lot of sense, especially given his situation. In 2002, Skeesuck was diagnosed with an autoimmune and neurological…
-
Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
